SCHEMBL8868460

SCHEMBL8868460

COC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3ccc(F)cc3)cc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
P4HTM Q9NXG6 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
BCL2L1 Q07817 1/20 0.45
MCL1 Q07820 1/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
PPARA Q07869 1/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868685 1.00 MAPT (0.52) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8868264 0.92 MAPT (0.52) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8869698 0.92 PPARA (0.53) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8868236 0.92 P4HTM (0.51) MAPTP4HTMMEN1KMT2APPARA
SCHEMBL8869066 0.92 PPARA (0.53) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8868676 0.91 MAPT (0.49) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8869129 0.91 MAPT (0.49) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8868766 0.91 P4HTM (0.59) MAPTP4HTMMEN1KMT2ACA1
SCHEMBL8869630 0.91 MAPT (0.53) MAPTP4HTMMEN1KMT2ABCL2L1
SCHEMBL8868306 0.91 MAPT (0.53) MAPTP4HTMMEN1KMT2ABCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed